Blackrock Neurotech

Blackrock Neurotech (formerly Blackrock Microsystems) is the manufacturer of the Utah Array, the most widely used intracortical electrode platform in human BCI research. The company supplies research-grade neural recording and stimulation systems to academic labs worldwide and holds multiple FDA IDEs for clinical use of the Utah Array in paralysis and epilepsy monitoring. Blackrock received a $200M investment from Tether in 2024 and FDA Breakthrough Device designation for its MoveAgain closed-loop system for spinal cord injury rehabilitation. The company also developed the Neuralace 10,000+ channel next-generation BCI. Peter Thiel is among its angel investors.